GenoFAB Inc.

Screening synthetic DNA orders is only one of the pieces of a cyberbiosecurity policy. Properly managing sequences and analyzing sequencing data are other important touchpoints. GenoFAB can help you streamline your plasmid operations. Want to learn more? Let's talk https://lnkd.in/gURRn2XR #plasmids #lablife #DNA #cloning #wholeplasmidsequencing #bioinformatics

The Jean Peccoud lab at Colorado State University used out PlasCAT software to analyze the reproducibility of whole plasmid sequencing pipelines using short reads from Illumina and long reads from Oxford Nanopore Technologies. Many commonly used plasmids are difficult to sequence, even when combining short and long reads. Check out the preprint at https://lnkd.in/edwAz5cy #synbio #syntheticbiology #lablife #bioinformatics #sequencing #reproducibility #DNA #biotechnology Contact GenoFAB Inc. if you need help verifying your plasmid collection.

VectorBuilder recently published a preprint showing that half of the plasmids developed in-house have design or structural problems. Their results are consistent with our own experience. This situation is concerning as it undermines the #reproducibility of research results, wasted R&D budgets, and unnecessary project completion delays. It can also compromise #patientsafety, may lead to #biosecurity incidents, and exposure to litigation risks. Contact GenoFAB Inc. to discuss strategies to ensure the integrity of your plasmids. #molecularbiology #viralvectors #genedelivery #biotechnology #synbio #syntheticbiology https://lnkd.in/gtxM5Fad

Reposting an edited version of an email sent by Kevin Noble to members of the Innosphere Ventures life science incubation program. Fifty years later, "Clone or die" is still the motto many #biotech companies live by. In the mid-1970s Genentech had adopted "Clone or Die" as their rallying charge and primary objective. This motto encapsulated the company's determination and the high stakes of their work. It was a rallying cry for the team, emphasizing the critical importance of their mission. The phrase "clone" referred to the cloning of genes, a fundamental process in genetic engineering. "Die" starkly underscored the consequences of failure—both for individual projects and potentially for the company itself. There was immense pressure on the small team at Genentech to produce results. The company's survival hinged on its ability to efficiently clone genes and produce recombinant proteins. Failure to do so would mean losing out to competitors and possibly going out of business. Genentech's intense focus and pioneering work paid off. The company achieved several key milestones, including the development of the first recombinant DNA drug, human insulin, in collaboration with Eli Lilly and Company. This success helped establish Genentech as a leader in biotechnology and paved the way for its future achievements. The "Clone or Die" motto remains a symbolic reminder of the company's early challenges and entrepreneurial spirit. The attached fictional representation might reflect what their initial #OKR might have looked like to support the "Clone or Die" objective. - Objective: Inspirational (lead the biotech industry); Action-Oriented (achieve breakthrough advancements in cloning technology); Time-Bound (within 18 months); and Qualitative (what will be achieved) - Key Results: Outcome-Focused (successfully clone a human gene); Measurable (3 peer-reviewed papers); Time-Bound (within x months) and Achievable - Actions and Tactics: An initial plan of how to achieve the stated outcomes  #startup #entrepreneurship #plasmid #synbio

GenoFAB is developing a new service to distribute standard and custom plasmids. The new service will improve the quality of the plasmid documentation, streamline the licensing process, clarify the intellectual property status of plasmids, and streamline the plasmid quality control process. We are interested in getting the perspective of potential users, including: - Biotechnology companies who need to access plasmids developed by third parties. - Academic and corporate developers of plasmids who want to license their plasmids to third parties for research purposes. - Biotech companies who need to control the distribution of their plasmids with business partners. Interested in getting early access to GenoFAB plasmid distribution service? Tell us how you purchase and distribute your plasmids by filling out this form: https://lnkd.in/gVqX4tEB #biotechnology #syntheticbiology #synbio #security #cyberbiosecurity #reproducibility #intellectualproperty #mta #plasmids #bioengineering #molecularbiology

The choice of a LIMS software solution is a critical element of a laboratory management strategy. Learn more about the top LIMS software solutions of 2024. https://bit.ly/3vOW5yN

Learn how our new patented DNA Identification Number (DIN) technology can help you better control the distribution of our your valuable plasmids https://bit.ly/49eOfgn

Kaitlyn Miller and I are looking forward to presenting GenoFAB Inc. at https://lnkd.in/gGgvpfdm today. We will argue that #biofoundries are transformative solutions to the #pharma industry chronic data problem. These infrastructures can produce the preclinical data needed to leverage the power of AI/ML to accelerate the development of biologic drugs #datascience #highthroughput #labautomation #biologics